Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain.

Murphy AL, Gardner DM, Kisely S, Cooke C, Kutcher SP, Hughes J.

ISRN Obes. 2013 Nov 20;2013:390130. doi: 10.1155/2013/390130. eCollection 2013.

PMID:
24533223
[PubMed]
Free PMC Article
2.

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

Maayan L, Correll CU.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Epub 2011 Dec 13. Review.

PMID:
22166172
[PubMed - indexed for MEDLINE]
3.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
[PubMed - indexed for MEDLINE]
4.

Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

Reeves GM, Keeton C, Correll CU, Johnson JL, Hamer RM, Sikich L, Hazzard L, Alderman C, Scheer A, Mabe M, Kapoor S, Sheridan E, Borner I, Bussell K, Pirmohamed S, Bethea TC, Chekuri R, Gottfried R, Reinblatt SP, Santana E, Riddle MA.

Child Adolesc Psychiatry Ment Health. 2013 Aug 15;7(1):31. doi: 10.1186/1753-2000-7-31.

PMID:
23947389
[PubMed]
Free PMC Article
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
6.

Cultural perceptions of healthy weight in rural Appalachian youth.

Williams KJ, Taylor CA, Wolf KN, Lawson RF, Crespo R.

Rural Remote Health. 2008 Apr-Jun;8(2):932. Epub 2008 May 22.

PMID:
18503293
[PubMed - indexed for MEDLINE]
Free Article
7.

[Antipsychotic prescription assessment in general practice: metabolic effects].

Gignoux-Froment F, de Montleau F, Saravane D, Verret C.

Encephale. 2012 Dec;38(6):453-9. doi: 10.1016/j.encep.2011.12.006. Epub 2012 Jan 23. French.

PMID:
23200610
[PubMed - indexed for MEDLINE]
8.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
[PubMed - indexed for MEDLINE]
9.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
[PubMed - indexed for MEDLINE]
10.

Weight change with atypical antipsychotics in the treatment of schizophrenia.

Haddad P.

J Psychopharmacol. 2005 Nov;19(6 Suppl):16-27. Review.

PMID:
16280334
[PubMed - indexed for MEDLINE]
11.

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.

Gentile S.

Drug Saf. 2006;29(4):303-19. Review.

PMID:
16569080
[PubMed - indexed for MEDLINE]
12.

Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.

Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, Gebhardt N, Remschmidt H, Krieg JC, Hebebrand J, Theisen FM.

J Psychiatr Res. 2009 Mar;43(6):620-6. doi: 10.1016/j.jpsychires.2008.11.001. Epub 2008 Dec 24.

PMID:
19110264
[PubMed - indexed for MEDLINE]
13.

Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

Citrome L, Holt RI, Walker DJ, Hoffmann VP.

Clin Drug Investig. 2011;31(7):455-82. doi: 10.2165/11589060-000000000-00000. Review.

PMID:
21495734
[PubMed - indexed for MEDLINE]
14.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Newcomer JW.

CNS Drugs. 2005;19 Suppl 1:1-93. Review.

PMID:
15998156
[PubMed - indexed for MEDLINE]
15.

[Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].

Koga M.

Seishin Shinkeigaku Zasshi. 2003;105(4):473-88. Japanese.

PMID:
12806910
[PubMed - indexed for MEDLINE]
16.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
[PubMed - indexed for MEDLINE]
17.

Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.

Wong MM, Chen EY, Lui SS, Tso S.

Clin Schizophr Relat Psychoses. 2011 Oct;5(3):135-41. doi: 10.3371/CSRP.5.3.3.

PMID:
21983497
[PubMed - indexed for MEDLINE]
18.

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.

Maayan L, Vakhrusheva J, Correll CU.

Neuropsychopharmacology. 2010 Jun;35(7):1520-30. doi: 10.1038/npp.2010.21. Epub 2010 Mar 24. Review.

PMID:
20336059
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment.

Skrede S, Fernø J, Bjørndal B, Brede WR, Bohov P, Berge RK, Steen VM.

PLoS One. 2012;7(11):e50853. doi: 10.1371/journal.pone.0050853. Epub 2012 Nov 30.

PMID:
23226405
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk